COVID-19 时代的皮肤病理学实践。
Dermatopathology practice in the era of COVID-19.
机构信息
Department of Dermatology, Faculty of Medicine, Kasr Alainy Hospital, Cairo University, Giza, Egypt.
出版信息
Arch Dermatol Res. 2021 Dec;313(10):811-813. doi: 10.1007/s00403-020-02183-x. Epub 2021 Feb 9.
Abstract
Coronavirus disease 2019 (COVID-19) pandemic has affected almost all aspects of our life including health care services. A lot of dermatopathology laboratories have stopped working during this pandemic. This article aims at reviewing the challenges and effects of COVID-19 on the practice of dermatopathology in view of the current guidelines.
摘要
2019 年冠状病毒病（COVID-19）大流行几乎影响了我们生活的方方面面，包括医疗保健服务。在这场大流行期间，许多皮肤科病理实验室已经停止工作。本文旨在根据当前的指南，回顾 COVID-19 对皮肤科病理实践的挑战和影响。
相似文献
1
Dermatopathology practice in the era of COVID-19.COVID-19 时代的皮肤病理学实践。
Arch Dermatol Res. 2021 Dec;313(10):811-813. doi: 10.1007/s00403-020-02183-x. Epub 2021 Feb 9.
2
Laboratory Biosafety Considerations of SARS-CoV-2 at Biosafety Level 2.实验室生物安全考虑 SARS-CoV-2 在生物安全级别 2 下的情况。
Health Secur. 2020 May/Jun;18(3):232-236. doi: 10.1089/hs.2020.0021. Epub 2020 Jun 9.
3
Biosafety measures for preventing infection from COVID-19 in clinical laboratories: IFCC Taskforce Recommendations.临床实验室预防 COVID-19 感染的生物安全措施：IFCC 工作组建议。
Clin Chem Lab Med. 2020 Jun 25;58(7):1053-1062. doi: 10.1515/cclm-2020-0633.
4
Disposable customized aerosol containment chamber for oral cancer biopsy: A novel technique during COVID-19 pandemic.用于口腔癌活检的一次性定制气溶胶收集盒：COVID-19大流行期间的一项新技术。
J Surg Oncol. 2020 Aug;122(2):120-121. doi: 10.1002/jso.25962. Epub 2020 May 12.
5
Application of Biosafety Principles in Laboratory Analysis of Clinical Samples from Patients with COVID-19.生物安全原则在新型冠状病毒肺炎患者临床样本实验室检测中的应用
J Pak Med Assoc. 2020 May;70(Suppl 3)(5):S48-S51. doi: 10.5455/JPMA.10.
6
Procedures for Flow Cytometry-Based Sorting of Unfixed Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infected Cells and Other Infectious Agents.基于流式细胞术的未固定严重急性呼吸综合征冠状病毒 2（SARS-CoV-2）感染细胞和其他传染性病原体的分选程序。
Cytometry A. 2020 Jul;97(7):674-680. doi: 10.1002/cyto.a.24040. Epub 2020 Jun 3.
7
SARS-CoV-2's origin should be investigated worldwide for pandemic prevention.为预防大流行，应在全球范围内调查新冠病毒的起源。
Lancet. 2021 Oct 9;398(10308):1299-1303. doi: 10.1016/S0140-6736(21)02020-1. Epub 2021 Sep 17.
8
Laboratory biosafety measures involving SARS-CoV-2 and the classification as a Risk Group 3 biological agent.实验室生物安全措施涉及 SARS-CoV-2 和被归类为 3 级风险的生物制剂。
Pathology. 2020 Dec;52(7):790-795. doi: 10.1016/j.pathol.2020.09.006. Epub 2020 Sep 30.
9
Challenges in the establishment of a biosafety testing laboratory for COVID-19 in Bangladesh.孟加拉国建立 COVID-19 生物安全检测实验室面临的挑战。
J Infect Dev Ctries. 2021 Dec 31;15(12):1833-1837. doi: 10.3855/jidc.14415.
10
Guidelines for various laboratory sections in view of COVID-19: Recommendations from the Indian Association of Pathologists and Microbiologists.鉴于新型冠状病毒肺炎的各实验室部门指南：印度病理学家和微生物学家协会的建议
Indian J Pathol Microbiol. 2020 Jul-Sep;63(3):350-357. doi: 10.4103/IJPM.IJPM_857_20.
本文引用的文献
1
Use of mouthwashes against COVID-19 in dentistry.牙科中使用漱口水预防新型冠状病毒肺炎
Br J Oral Maxillofac Surg. 2020 Oct;58(8):924-927. doi: 10.1016/j.bjoms.2020.08.016. Epub 2020 Aug 15.
2
Selection of parameters for thermal coronavirus inactivation - a data-based recommendation.新冠病毒热灭活参数的选择——基于数据的建议
GMS Hyg Infect Control. 2020 Jul 13;15:Doc16. doi: 10.3205/dgkh000351. eCollection 2020.
3
Propagation, Inactivation, and Safety Testing of SARS-CoV-2.SARS-CoV-2 的传播、灭活和安全性测试。
Viruses. 2020 Jun 6;12(6):622. doi: 10.3390/v12060622.
4
Biosafety in surgical pathology in the era of SARS-Cov2 pandemia. A statement of the Italian Society of Surgical Pathology and Cytology.SARS-CoV2大流行时代外科病理学中的生物安全。意大利外科病理学和细胞学会声明。
Pathologica. 2020 Jun;112(2):59-63. doi: 10.32074/1591-951X-14-20. Epub 2020 Apr 1.
5
Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1.与严重急性呼吸综合征冠状病毒1（SARS-CoV-1）相比，严重急性呼吸综合征冠状病毒2（SARS-CoV-2）在气溶胶和表面的稳定性
N Engl J Med. 2020 Apr 16;382(16):1564-1567. doi: 10.1056/NEJMc2004973. Epub 2020 Mar 17.
6
The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2.严重急性呼吸综合征相关冠状病毒：将 2019-nCoV 进行分类并命名为 SARS-CoV-2。
Nat Microbiol. 2020 Apr;5(4):536-544. doi: 10.1038/s41564-020-0695-z. Epub 2020 Mar 2.
7
Coronavirus Disease 2019: Coronaviruses and Blood Safety.2019 年冠状病毒病：冠状病毒与血液安全。
Transfus Med Rev. 2020 Apr;34(2):75-80. doi: 10.1016/j.tmrv.2020.02.003. Epub 2020 Feb 21.
8
Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS-CoV-2 infection.评估 SARS-CoV-2 感染患者的泪液和结膜分泌物中的冠状病毒。
J Med Virol. 2020 Jun;92(6):589-594. doi: 10.1002/jmv.25725. Epub 2020 Mar 12.
9
Consistent Detection of 2019 Novel Coronavirus in Saliva.唾液中 2019 新型冠状病毒的持续检测。
Clin Infect Dis. 2020 Jul 28;71(15):841-843. doi: 10.1093/cid/ciaa149.
10
Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents.冠状病毒在无生命表面上的持久性及其用杀生物剂灭活。
J Hosp Infect. 2020 Mar;104(3):246-251. doi: 10.1016/j.jhin.2020.01.022. Epub 2020 Feb 6.
Zotero 插件